Mayuresh Joshi says: “Sun Pharma, Cipla and Lupin probably remain as holds in our global portfolios. From an earnings perspective, Torrent Pharma and JV Chemicals on declines or pullbacks can probably be looked at. Again, the key triggers remain the same across both these stocks.” The comfort stays with largecaps from a valuation perspective as a whole host of mid/small caps have run up quite significantly.
The 52-week high holds significant importance as a technical indicator for traders and investors, indicating a stock s highest price over the preceding year.
We filtered this selection by incorporating stocks exclusively held by an MF scheme with a market value surpassing Rs 10 crore as of October 2023, and those experiencing a price surge of over 50% in the fiscal year 2023-24.
Revolutionising marketing: Where data takes the lead in a digital age indiantelevision.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiantelevision.com Daily Mail and Mail on Sunday newspapers.